Status:
UNKNOWN
Correlations Between Oxidative Stress Biomarkers, h-FABP and Left Ventricular Dysfunction in Patients With Acute Myocardial Infarction Undergoing Primary PCI
Lead Sponsor:
Grigore T. Popa University of Medicine and Pharmacy
Collaborating Sponsors:
Cardiovascular Diseases Institute IASI, Romania
Conditions:
STEMI
Oxidative Stress
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators intend to evaluate Oxidative Stress biomarkers through a. Catalase Activity Assay; b. Lipid Peroxidation Assay; c. SOD Assay; d. Total Antioxidant Capacity Assay; e. Glutathione Pero...
Detailed Description
Gathered data: * Descriptive general demographic data; * Previous pathologies (ischemic heart disease, peripheral arterial disease, stroke, heart failure, previous percutaneous coronary interventions...
Eligibility Criteria
Inclusion
- Adults with ST elevation Myocardial Infarction (\<12h) diagnostic confirmed;
- Included in the Romanian National Programme of Primary Percutaneous Revascularisation (for who the Guidelines recommend primary PCI);
Exclusion
- Patients who do not sign informed consent for primary PCI
Key Trial Info
Start Date :
August 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04034940
Start Date
August 1 2019
End Date
August 1 2020
Last Update
July 30 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiovascular Diseases Institute Iasi
Iași, Iaşi, Romania, 700503